Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Whitehawk Therapeutics (WHWK) Change in Acquisitions & Divestments: 2017-2024

Historic Change in Acquisitions & Divestments for Whitehawk Therapeutics (WHWK) over the last 4 years, with Dec 2024 value amounting to $63.3 million.

  • Whitehawk Therapeutics' Change in Acquisitions & Divestments fell 86.86% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.4 million, marking a year-over-year decrease of 51.16%. This contributed to the annual value of $63.3 million for FY2024, which is 58.23% down from last year.
  • As of FY2024, Whitehawk Therapeutics' Change in Acquisitions & Divestments stood at $63.3 million, which was down 58.23% from $151.6 million recorded in FY2023.
  • In the past 5 years, Whitehawk Therapeutics' Change in Acquisitions & Divestments ranged from a high of $151.6 million in FY2023 and a low of $12.8 million during FY2022.
  • For the 3-year period, Whitehawk Therapeutics' Change in Acquisitions & Divestments averaged around $75.9 million, with its median value being $63.3 million (2024).
  • As far as peak fluctuations go, Whitehawk Therapeutics' Change in Acquisitions & Divestments soared by 1,089.15% in 2023, and later slumped by 58.23% in 2024.
  • Yearly analysis of 3 years shows Whitehawk Therapeutics' Change in Acquisitions & Divestments stood at $12.8 million in 2022, then skyrocketed by 1,089.15% to $151.6 million in 2023, then plummeted by 58.23% to $63.3 million in 2024.